Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Ravelli

Showing results (61-70 of 341) with videos related to

Pageof 35
Sort By:
Frontiers in Pharmacology|December 22, 2016
IL-1 Inhibition in Systemic Juvenile Idiopathic ArthritisGabriella Giancane, Francesca Minoia, Sergio Davì, et al.
Rheumatology and Therapy|October 18, 2016
Juvenile Idiopathic Arthritis: Diagnosis and TreatmentGabriella Giancane, Alessandro Consolaro, Stefano Lanni, et al.
Autoimmunity|June 14, 2006
Clinical assessment in juvenile dermatomyositisAngelo Ravelli, Nicolino Ruperto, Lucia Trail, et al.
Expert Review of Clinical Immunology|June 18, 2021
Novel biomarkers for prediction of outcome and therapeutic response in juvenile idiopathic arthritisSilvia Rosina, Valentina Natoli, Stefania Santaniello, et al.
Clinical and Experimental Rheumatology|October 3, 2017
Open issues in the assessment and management of pain in juvenile idiopathic arthritisGabriella Giancane, Alessandra Alongi, Silvia Rosina, et al.
Arthritis and Rheumatism|October 29, 2005
Patterns of clinical remission in select categories of juvenile idiopathic arthritisCarol A Wallace, Bin Huang, Marcia Bandeira, et al.
Arthritis Care & Research|May 17, 2012
Measures of disease activity and damage in pediatric systemic lupus erythematosus: British Isles Lupus Assessment Group (BILAG), European Consensus Lupus Activity Measurement (ECLAM), Systemic Lupus Activity Measure (SLAM), Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), Physician's Global Assessment of Disease Activity (MD Global), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SLICC/ACR DI; SDI)Bianca Lattanzi, Alessandro Consolaro, Nicoletta Solari, et al.
Clinical and Experimental Rheumatology|January 12, 2016
Recurrent macrophage activation syndrome in spondyloarthritis and monoallelic missense mutations in PRF1: a description of one paediatric caseGiovanni Filocamo, Antonella Petaccia, Marta Torcoletti, et al.
Clinical and Experimental Rheumatology|October 18, 2012
Toward a treat-to-target approach in the management of juvenile idiopathic arthritisAlessandro Consolaro, Giorgia Negro, Stefano Lanni, et al.
Frontiers in Pediatrics|June 28, 2021
Multisystem Inflammatory Syndrome in Children: Unique Disease or Part of the Kawasaki Disease Spectrum?Caterina Matucci-Cerinic, Roberta Caorsi, Alessandro Consolaro, et al.
Pageof 35

Showing results (61-70 of 341) with videos related to

Sort By:
Pageof 35
Frontiers in Pharmacology|December 22, 2016
IL-1 Inhibition in Systemic Juvenile Idiopathic ArthritisGabriella Giancane, Francesca Minoia, Sergio Davì, et al.
Rheumatology and Therapy|October 18, 2016
Juvenile Idiopathic Arthritis: Diagnosis and TreatmentGabriella Giancane, Alessandro Consolaro, Stefano Lanni, et al.
Autoimmunity|June 14, 2006
Clinical assessment in juvenile dermatomyositisAngelo Ravelli, Nicolino Ruperto, Lucia Trail, et al.
Expert Review of Clinical Immunology|June 18, 2021
Novel biomarkers for prediction of outcome and therapeutic response in juvenile idiopathic arthritisSilvia Rosina, Valentina Natoli, Stefania Santaniello, et al.
Clinical and Experimental Rheumatology|October 3, 2017
Open issues in the assessment and management of pain in juvenile idiopathic arthritisGabriella Giancane, Alessandra Alongi, Silvia Rosina, et al.
Arthritis and Rheumatism|October 29, 2005
Patterns of clinical remission in select categories of juvenile idiopathic arthritisCarol A Wallace, Bin Huang, Marcia Bandeira, et al.
Arthritis Care & Research|May 17, 2012
Measures of disease activity and damage in pediatric systemic lupus erythematosus: British Isles Lupus Assessment Group (BILAG), European Consensus Lupus Activity Measurement (ECLAM), Systemic Lupus Activity Measure (SLAM), Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), Physician's Global Assessment of Disease Activity (MD Global), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SLICC/ACR DI; SDI)Bianca Lattanzi, Alessandro Consolaro, Nicoletta Solari, et al.
Clinical and Experimental Rheumatology|January 12, 2016
Recurrent macrophage activation syndrome in spondyloarthritis and monoallelic missense mutations in PRF1: a description of one paediatric caseGiovanni Filocamo, Antonella Petaccia, Marta Torcoletti, et al.
Clinical and Experimental Rheumatology|October 18, 2012
Toward a treat-to-target approach in the management of juvenile idiopathic arthritisAlessandro Consolaro, Giorgia Negro, Stefano Lanni, et al.
Frontiers in Pediatrics|June 28, 2021
Multisystem Inflammatory Syndrome in Children: Unique Disease or Part of the Kawasaki Disease Spectrum?Caterina Matucci-Cerinic, Roberta Caorsi, Alessandro Consolaro, et al.
Pageof 35